Latest News in the pharma Industry

Market News

Allergan obatins worldwide rights to microbiome GI development programs

Allergan obatins worldwide rights to microbiome GI development programs

10 Jan 2017

Deal expands Allergan's innovative GI [ipeline with ABI-M201 and ABI-M301, preclinical compounds targeting Uucerative colitis and Crohn's disease, as well as future compounds for irritable bowel syndrome.

Read more 
Takeda and PvP Biologics sign development agreement around novel therapeutic for celiac disease

Takeda and PvP Biologics sign development agreement around novel therapeutic for celiac disease

9 Jan 2017

KumaMax could provide hope celiac patients who try, but are unable to completely avoid gluten exposure in their diets,

Read more 
Catalent to develop softgel capsules for JOT's leading orphan disease candidates

Catalent to develop softgel capsules for JOT's leading orphan disease candidates

9 Jan 2017

JOTROL is being developed to remedy resveratrol’s poor bioavailability and dose limiting gastrointestinal side effects.

Read more 
Cardinal Health reaches $20 million settlement with West Virginia

Cardinal Health reaches $20 million settlement with West Virginia

9 Jan 2017

Company collaborating with all participants in the pharma supply chain to tackle to the epidemic of prescription drug abuse.

Read more 
Ariad to be acquired by Takeda for $5.2 billion

Ariad to be acquired by Takeda for $5.2 billion

9 Jan 2017

Ariad stockholders to receive $24.00 per share in cash.

Read more 
Ascendia Pharmaceuticals awarded new patent on its ASD-002 program for acute coronary syndrome

Ascendia Pharmaceuticals awarded new patent on its ASD-002 program for acute coronary syndrome

9 Jan 2017

A ready-to-use, stable and soluble, parenteral form of clopidogrel is feasible using the company's nanoemulsion platform technology.

Read more 
Lilly to adjust organization and leadership structure

Lilly to adjust organization and leadership structure

5 Jan 2017

Christi Shaw hired to lead Bio-Medicines; Conterno to assume additional geographic responsibilities, including Lilly USA leadership; Zulueta to lead International business.

Read more 
BMS and Janssen to collaborate to evaluate Opdivo in combination with Darzalex

BMS and Janssen to collaborate to evaluate Opdivo in combination with Darzalex

5 Jan 2017

Phase Ib/II studies to explore a novel immuno-oncology combination in hematological and solid tumours with high unmet medical need.

Read more 
Noxxon Pharma licenses and assigns preclinical  Spiegelmer programs to Aptarion

Noxxon Pharma licenses and assigns preclinical Spiegelmer programs to Aptarion

5 Jan 2017

Noxxon continues transition to clinical oncology company.

Read more 
Lonza concludes divestment of peptides business and operations in Braine-l’Alleud, Belgium

Lonza concludes divestment of peptides business and operations in Braine-l’Alleud, Belgium

4 Jan 2017

PolyPeptide Laboratories' acquisition brings immediate access to additional large-scale capacity in synthesis, purification and isolation of peptides.

Read more 
RedHill Biopharma announces exclusive US co-promotion agreement with Concordia for GI drug Donnatal

RedHill Biopharma announces exclusive US co-promotion agreement with Concordia for GI drug Donnatal

4 Jan 2017

Concordia will continue to be responsible for the manufacturing and supply of Donnatal in all territories.

Read more 
Directorate change at Shire

Directorate change at Shire

3 Jan 2017

Appointment of Ian Clark as Non-Executive Director.

Read more